top of page

About TACT Genomics


Innovation in genomics is a key solution to elucidating molecular biology, uncovering molecular pathology, and conquering cancer and other diseases.


  • Develop innovative scientific tools to advance in biological and medical research, and assist in the definitive detection of cancer and the treatment of complex diseases.

  • Supply excellent biological reagents to enhance research innovation in molecular biology, genomic characterization, and disease mechanisms.


TACT Genomics is a biotech & preclinical startup, with expertise in significant basic science and clinical research that facilitates precision diagnosis and customized treatment to patients with cancer. Our expertise includes cell and molecular biology, gene expression, in vitro disease models, preclinical & clinical development, biomarker identification,  development of quantitative molecular assays, and more.

Our Platform is Growing.
bottom of page